SAN CARLOS, Calif., Nov 01, 2006 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) will be presenting a company overview and update at three conferences in the next few weeks.
1. Cowen & Company 7th Annual Global Health Care Conference in London, on Tuesday, November 7, 2006 at 8:40am (UK Time) with Dr. Chris Searcy, vice president of corporate development, as the speaker.
2. CIBC 17th Annual Healthcare Conference in New York, on Tuesday, November 7, 2006 at 10:20am (Eastern Time), with Rob Chess, chairman and acting president and chief executive officer, as the speaker.
3. Lehman Brothers Small Cap Conference in Dana Point, California, on Friday, November 17, 2006 at 9:20am (Pacific Time), with Lou Drapeau, senior vice president of finance and chief financial officer as the speaker.
The live presentations will be webcast and may be accessed on the Investor Relations' page at www.nektar.com and will be available for two weeks following each webcast.
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. Nektar technology and know-how have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its drug delivery technologies and expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138 Jennifer Ruddock, 650-631-4954
Copyright Business Wire 2006
News Provided by COMTEX